Navigation Links
Varian Medical Systems to Exhibit Cancer Treatment and X-ray Imaging Technologies at China Med Exhibition
Date:3/16/2009

Varian to showcase products ranging from treatment planning software for radiation therapy to flat panel detectors for filmless X-ray imaging

BEIJING, March 16 /PRNewswire-FirstCall/ -- Varian Medical Systems, Inc. (NYSE: VAR) will showcase the full spectrum of the company's cancer treatment and X-ray imaging products, including some made available for the first time in China, at the upcoming China Med 21st International Medical Instruments and Equipment Exhibition in Beijing from March 19-21.

Varian will exhibit:

  • The Clinac iX medical linear accelerator, a radiation therapy machine that was introduced into China last year. This treatment machine incorporates a three-dimensional X-ray imager to improve tumor targeting. It can also be upgraded to deliver RapidArc(TM) radiotherapy, which enables doctors to deliver highly-precise image-guided radiotherapy treatments two to eight times faster than was previously possible.
  • Varian's market-leading medical software products, including Eclipse(TM) radiotherapy treatment planning software and ARIA(R) cancer treatment management software.
  • The GammaMedplus(TM) afterloader, a machine for delivering brachytherapy, which is a way of treating cancer by placing tiny radiation sources directly into a targeted tumor.
  • A broad array of X-ray tubes and the company's PaxScan(R) line of flat-panel digital X-ray image detectors, which are used for filmless imaging in medical, dental, and other applications.

"Varian is committed to offering customers the largest selection of X-ray tubes and digital image detectors to serve in a broad range of applications," said Hsiao-Li Pan, manager of Varian's X-ray products distribution business in China. "We will exhibit a variety of
'/>"/>

SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results
2. Pivotal Data Published For First Biomarker Combination Test to Determine Risk of Ovarian Cancer in Women Who Present With Pelvic Mass
3. A Milestone in Cancer Genetics: deCODE Discovers First Common Genetic Variants Affecting the Risk of Many Types of Cancer
4. Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE(R)
5. Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium
6. Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine
7. AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108
8. Experts Assert That Varian Technologies Deliver Speed and Clinical Accuracy in Treating Cancer Patients
9. deCODE and Radboud University Discover Common Variants in the Human Genome Conferring Risk of Bladder Cancer
10. 96-Well Filtration Plate From Varian, Inc. Improves Sensitivity and Precision for Trace Bio-Analysis by LC/MS
11. Variant of Mad Cow Disease May Be Transmitted by Blood Transfusions, According to Animal Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Utah , Aug. 29, 2014  BC Technical, ... has acquired Polaris Medical Imaging, a leader in sales, ... This strategic acquisition allows BC Technical to continue to ... specifically within MR and CT modalities. ... service," said Mark Alvarez , president and CEO ...
(Date:8/29/2014)... -- Research and Markets has announced the ... & Pipeline Insight 2014" report to their offering. ... and eradicate the prevalence of cancer have achieved limited ... low specificity, safety and large number of side effects, ... solution. It has been discovered that peptides can be ...
(Date:8/29/2014)... August 29, 2014 According ... Market by Extraction type (SFE, Cold Pressed, Organic ... Care, Pharmaceutical, Food Supplements, Fragrance, & Others) - Global ... defines and segments the Amaranth Seed Oil Market ... size in terms of value. The Amaranth Seed ...
Breaking Medicine Technology:BC Technical Acquires Polaris Medical Imaging 2Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4
... 4 Shire plc ... biopharmaceutical company, today announced that the US Food and ... information for its once-daily Attention Deficit Hyperactivity Disorder (ADHD) ... CII, to include supplemental data demonstrating significant improvement in ...
... , May 4 Kaiser Permanente, committed to improving the ... require suppliers to provide environmental data for $1 billion worth ... other facilities. , , , ... Scorecard is the first of its kind in health care. It will ...
Cached Medicine Technology:FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD 2FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD 3FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD 4FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD 5FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD 6FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD 7FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD 8Kaiser Permanente Launches Sustainability Scorecard for Medical Products 2Kaiser Permanente Launches Sustainability Scorecard for Medical Products 3
(Date:9/1/2014)... Mass., (PRWEB) September 01, 2014 BCC ... BLOOD-BRAIN BARRIER TECHNOLOGIES AND GLOBAL MARKETS , ... $21.8 million in 2013 and is expected to reach ... grow to $471.5 million by 2019, which is equivalent ... through 2019. The receptor-mediated transport (RMT) segment is forecasted ...
(Date:9/1/2014)... 01, 2014 Registration is now open for ... and 1-Mile Race to be held on Sunday, September 21, ... Yard at Harmon Meadow in Secaucus, New Jersey. All proceeds ... national nonprofit dedicated to restoring a sense of self, restoring ... and our military families. , General registration is $30 with ...
(Date:9/1/2014)... 2014 The Outlier Series announced the ... interview content from one of the exceptional women featured ... Women Game Changers . The title of the upcoming ... Changer Jenny McClendon . McClendon is currently a full-time ... the star of WeTV show, Raising Sextuplets. , Jenny ...
(Date:9/1/2014)... Vegas, Nevada (PRWEB) September 01, 2014 ... host to over 3,000 medical professionals and 10,000 consumers ... Week is a 5-day gathering of the nation’s top ... its associated diseases or conditions. The week-long event contains ... relevant evidence-based scientific instruction available in the pain management ...
(Date:8/31/2014)... (PRWEB) August 31, 2014 MYMOBILEUNI ... community utilizing social media marketing tools access to ... programs. MMU will utilize all tools to reach ... partner for our multiple learning channels. , MMU, ... app, and an authoring tool that applies social ...
Breaking Medicine News(10 mins):Health News:Global Market for Blood-Brain Barrier (BBB) Technology to Reach $471.5 Million in 2019; Highest CAGR Growth in Latin American Market With 10.5% 2Health News:Global Market for Blood-Brain Barrier (BBB) Technology to Reach $471.5 Million in 2019; Highest CAGR Growth in Latin American Market With 10.5% 3Health News:Hope For The Warriors New Jersey Run to Honor Wounded and Families of the Fallen 2Health News:Upcoming Outlier Series eBook about Jenny McClendon, PA-C, Former Start of Raising Sextuplets 2Health News:Upcoming Outlier Series eBook about Jenny McClendon, PA-C, Former Start of Raising Sextuplets 3Health News:Medical Marijuana Doctor Company Set to Present at Las Vegas Pain Week 2Health News:My Mobile University Announces Global Strategic Plan and Unveils New Android App to Enhance and Impact Lives World-Wide Through Education for All as Learning Platform 2Health News:My Mobile University Announces Global Strategic Plan and Unveils New Android App to Enhance and Impact Lives World-Wide Through Education for All as Learning Platform 3
... Don,t Disclose Depression to Their Physicians , Many adults ... of depression to their primary care physician. In a ... one or more reasons for not talking to a ... frequently cited reason being concern the physician would recommend ...
... to reduce federal health care spending in a socially ... letter to the Congressional Joint Committee on ... "On behalf of ACP,s 132,000 members, ACP ... framework to achieve hundreds of billions of dollars in ...
... , MONDAY, Sept. 12 (HealthDay News) -- Women with ... risk of developing breast and ovarian cancers, are being diagnosed ... ,We found with some mathematical modeling about a ... Jennifer Litton, a breast medical oncologist at the University of ...
... 12, 2011 The American Society for Gastrointestinal Endoscopy ... its program specifically dedicated to promoting quality in endoscopy, ... United States. The ASGE Endoscopy Unit Recognition Program honors ... quality assurance, endoscope reprocessing and CDC infection control guidelines. ...
... BVES butts heads with colorectal cancer Once a ... to a distant site it becomes much harder to treat. ... Williams, at Vanderbilt University School of Medicine, Nashville, has now ... progression to this dangerous state, leading them to suggest that ...
... multi-disciplinary expert panel, convened by the American Dental Association ... month containing clinical recommendations that sugar-free chewing gum, lozenges ... and a prescription varnish with chlorhexidine and thymol could ... to a comprehensive cavity prevention program which includes ...
Cached Medicine News:Health News:September/October 2011 Annals of Family Medicine Tip Sheet 2Health News:September/October 2011 Annals of Family Medicine Tip Sheet 3Health News:September/October 2011 Annals of Family Medicine Tip Sheet 4Health News:September/October 2011 Annals of Family Medicine Tip Sheet 5Health News:September/October 2011 Annals of Family Medicine Tip Sheet 6Health News:September/October 2011 Annals of Family Medicine Tip Sheet 7Health News:September/October 2011 Annals of Family Medicine Tip Sheet 8Health News:Reduce health care spending in socially and fiscally responsible manner, ACP to Congress 2Health News:Women With BRCA Mutations Get Cancer Diagnosis Earlier Than Before 2Health News:Women With BRCA Mutations Get Cancer Diagnosis Earlier Than Before 3Health News:ASGE recognizes 21 endoscopy units for quality and safety 2Health News:ASGE recognizes 21 endoscopy units for quality and safety 3Health News:JCI online early table of contents: Sept. 12, 2011 2Health News:JCI online early table of contents: Sept. 12, 2011 3Health News:JCI online early table of contents: Sept. 12, 2011 4Health News:JCI online early table of contents: Sept. 12, 2011 5Health News:JCI online early table of contents: Sept. 12, 2011 6Health News:JCI online early table of contents: Sept. 12, 2011 7Health News:JCI online early table of contents: Sept. 12, 2011 8Health News:Sugar-free polyol gum, lozenges, hard candy; Nonfluoride varnishes help prevent cavities 2Health News:Sugar-free polyol gum, lozenges, hard candy; Nonfluoride varnishes help prevent cavities 3
... potent glucocorticoid produced by the human ... is bound with high affinity to ... loosely bound to albumin. Cortisol acts ... in numerous physiologic systems, including immune ...
... or somatomedin C) is a 7.6 kDa peptide ... a potent mitogen of cellular proliferation, exerting its ... the circulation, IGF-I is bound to IGF-binding proteins ... IGF-I by modulating the interaction of IGF-I with ...
... somatomedin C) is a 7.6 kDa peptide produced ... potent mitogen of cellular proliferation, exerting its actions ... circulation, IGF-I is bound to IGF-binding proteins (IGFBPs), ... by modulating the interaction of IGF-I with the ...
Urovac bladder evacuator with adaptor...
Medicine Products: